Astellas Pharma Inc. (Astellas), a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. Astellas not only focuses on traditional prescription medications (Rx) but also explores…
Analysis
Hidden champion
Astellas Pharma Inc. is what we call a hidden champion: a strong business that the market is not pricing as one.
The price is attractive. You pay 8.4× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -6% yearly growth; analysts expect 17%. The price, in other words, assumes less than the experts do.
The trajectory is solid and the balance sheet is sturdy. The company scores 20/20 on our value-creation score: strong value creator.
Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202355
66
2023202420252026
All-time high
93
Feb 2026
All-time low
12
Jan 2024
Average rank
62
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
64
74
59
50
Price/Earnings
74
42
58
80
Price/Book
71
41
45
53
Dividend Yield
99
96
93
82
Value (overall)
98
74
50
57
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.